News Archive

Dr. Florian Brill has been appointed as a member of the Sector Committee Health Care by DAkkS Deutsche Akkreditierungsstelle GmbH. The appointment is valid from 21 November 2017 to 20 November 2020. The Sector Committees are important expert committees for the DAkkS. They elaborate rules and procedures for the technical assessment of conformity assessment bodies. Further information on the Sector Committees can be found here: http://www.dakks.de/en/content/committees

In the "tagesschau" of the ARD (First German Television program) from 13/09/2017 a sequence with laboratory tests can be seen, which has been produced in our laboratory. The complete film can be found at tagesschau.de under the following link: http://www.tagesschau.de/multimedia/video/video-327459.html

Since 1 September 2017 the Vice Chairman of our Scientific Advisory Board, Professor Jörg Steinmann, is Medical Director of the Institute of Clinical Hygiene, Medical Microbiology and Clinical Infectiology at the Paracelsus Medical Private University in the Nuremberg Hospital, as successor to Professor Just. The institute is one of the largest of its kind in Germany and offers a comprehensive range of methods for the diagnosis of the most important infectious agents for diagnostic (laboratory), therapeutic (AMS) as well as hospital-hygienic questions. We sincerely congratulate Professor Steinmann, wish him a successful start and are delighted that his expertise continuous to remain to the Scientific Advisory Board of Dr. Brill + Partner GmbH Institute for Hygiene and Microbiology.https://www.brillhygiene.com/en/company/advisory-board/univ-prof-dr-med-j%C3%B6rg-steinmann-vice-chairman

At the beginning of June, the Federal Council adopted the ordinance on evaporative cooling systems, cooling towers and wet separators (42nd BImSchV) with amendments. Among other things, this stipulates that the plants must be examined for legionella regularly in order to prevent legionella outbreaks. The entry into force of the regulation is expected in July 2017. The Federal Environment Agency (UBA) has already submitted recommendations for the sampling and verification of legionellae in the affected plants in order to standardize the procedure during the investigation of the plants. If you have any questions concerning the implementation of the regulation, we are happy to assist you. Our institute fulfills all requirements placed on the testing laboratory.Download: Recommendation for the sampling and detection of legionella in evaporative cooling systems, cooling towers and wet separators (source: Federal Environment Agency (Umweltbundesamt - UBA))https://www.umweltbundesamt.de/sites/default/files/medien/355/dokumente/nachweis_legionellen_verordnung_final.dotx.pdf

This year, we support the ICPIC Fellow Support Program. The program funds one participant from a low-income country to ensure a truly global meeting and to allow also such less fortunate colleagues to share their experiences.

We kindly request you to actively support us by submitting abstracts to the topics of the conference. Please make sure that you do not miss the chance to present your latest results on the topics mentioned below. Your posters and oral presentations will be evaluated by our scientific committee. Deadline for abstract submission is on August 31, 2017.- Topics: Applied Hygiene, Microbiology, Virology- Please use the following structure for your abstract: Background, Methods, Results, Conclusion- Please limit your abstract to a maximum of 200 words and mention a title as well as all authors including their affiliation- Please mark the presenting author- Please send your abstract as word file to Mr Steffen Pahl: Steffen.Pahl@brillhygiene.comCall for Sponsors:Various sponsoring packages are available. For all sponsorship options please contact Mrs Gesche von der Lieth: Gesche.vonderLieth@brillhygiene.com

From June 20 – 23, 2017 the ICIPIC 2017 will be held in Geneva. During this conference the scientists of Dr. Brill + Partner GmbH Institute for Hygiene and Microbiology will contribute their valuable knowledge to the scientific conference program. The following topics will be presented in Geneva:Poster viewing IIUrinary tract infectionsThursday 22 June 2017 | 08:00 - 18:00Abstract P243: STUDY ON THE DECONONISATION OF URINARY TRACT CATHETERS APPLAYING A PRACTICE-LIKE IN VITRO TEST METHODPresenter: Steffen PahlPoster viewing IIHand hygiene: in-vitro to in-vivoThursday 22 June 2017 | 08:00 - 18:00Abstract P330: VIRUCIDAL ACTIVITY OF WHO-HAND RUB FORMULATIONS AGAINST ENVELOPED VIRUSES INCLUDING ZIKA, EBOLA AND EMERGING CORONAVIRUSESPresenter: Dr. Florian H. H. BrillThe entire scientific conference program can be found at:http://www.icpic.com/conference-2017/scientific/programme-overview/

We are glad to announce that we were able to engage the well-known experts Professor Dr. Günter Kampf and Professor Dr. Andreas Voss as speakers for our Conference of Applied Hygiene, Microbiology and Virology (Hamburg, 02.-03.11.2017). Professor Kampf will cover the topic "Key Elements to Ensure Clinically Relevant Efficacy Data for Alcohol-Based Hand Rubs". Professor Voss will speak about "Infection Prevention and Control – Current and Future Hot Topics and Clinical Changes". In addition to external and internal speakers, the program includes presentations by Dr. Florian Brill, Professor Dr. Eike Steinmann, PD Dr. Jörg Steinmann as well as Dr. Jochen Steinmann. Please click here for the complete program: https://www.brillhygiene.com/en/akademie/termine/3rd-conference-applied-hygiene-microbiology-and-virology

Bremen, 10.-12. Mai 2017 - Im Rahmen der Sitzung "Hygiene, z. B. wie komme ich an Keime, die unter Plaque sitzen?" werden auf dem diesjährigen Deutschen Wundkongress folgende Vorträge von Mitarbeitern unseres Instituts gehalten: Dr. Florian H. H. Brill - "Biofilme in chronischen Wunden: Entstehung und klinische Relevanz für die Wundheilung", sowie Steffen Pahl - "Antimikrobielle Behandlung chronischer Wunden: Was sind die Mittel der Wahl?". Die Sitzung wird geleitet von Jan Forster (W41 - Raum 4 A, Do. 11.05.17, 16:00 - 17:30 Uhr, Kategorie: Therapie, Link: http://pp-wfb.convent-info.de/wufKeMZmQuEOKsFm1WAzmG/$/)

At this year's EWMA congress, an E-poster with the title "The risk to develop bacterial resistance against silver in wound care - updated evaluation of published data" has been presented (03/05/2017, E-poster Screen 2). Link: http://ewma.conference2web.com/#!contentsessions/22432Johannes Georg Böttrich (1), Horst Braunwarth (2), Joachim Dissemond (3), Hilt Joerg (4), Karl-Christian Münter (5), Patricia Wilken (6)(1) B.Braun Melsungen AG, Medical Scientific Affairs Opm, Melsungen, Germany(2) Coloplast GmbH, Hamburg, Germany(3) University Hospital of Essen, Abteilung für Dermatologie, Essen, Germany(4) Smith & Nephew GmbH, Hamburg, Germany(5) Gemeinschaftspraxis, General Medicine, Phlebology, Hamburg, Germany(6) Urgo GmbH, Sulzbach, GermanyAim:The increasing emergence of resistances presents a big challenge for medical treatment procedures like local therapy of wounds with local signs of infection. The aim of this survey was to update our analysis on the risk to develop bacterial resistance against ionic silver [Braunwarth 2014].Method:Based on published data a structured Pub Med-Search was conducted (2013/01/01 to 2016/10/31) with the following search terms: silver / resistance, silver / bacterial resistance, silver / bacterial tolerance, silver / bacterial susceptibility, silver / tolerance and silver / susceptibility. In addition an Embase search with the search terms Silver / antimicrobial / resistance was realized. All papers relevant to these terms were includedResults / Discussion:Out of 991 publications (PubMed 309; Embase 682) 17 were finally included. Main key results:- Only a few silver resistant bacteria were isolated [Sterling 2014].- Antibiotics appear to bear more resistance determinants than antiseptics [Murray 2015].- The universal susceptibility of staphylococci to Ag+ and failure to select for resistance to Ag+ underline advantages of silver- over antibiotics-therapy [Randall 2013].- Mobile genetic elements [Mijnendoncks 2013] and reduction of Ag+-ions [Muller & Merrett 2014; Finley 2015] are discussed as resistance mechanisms.- Silver can probably restore/improve the action of antibiotics against GN-bacteria [Morones-Ramirez 2013].- Although silver resistance is of concern [Sterling 2014] it is exceptionally rare and generally of no clinical relevance [Marx & Barillo 2014].Conclusion:This search indicates that silver resistance is apparently of no clinical relevance in wound care.

We support the association Waisenmedizin as a member. The mission of the association is to combat the inequity of access to basic healthcare and medicines at a global scale. The non-governmental organization brings forward non-for-profit projects, which help serve patients in need with diseases neglected by industrial research and development (R&D). A major concern is the infection disease leishmaniasis. More information at https://waisenmedizin.org/

Im Rahmen unserer Re-Akkreditierung haben wir eine flexible Akkreditierung der Kategorie II auch für viruzide Wirksamkeitsprüfungen in Phase 2 Stufe 1 und Phase 2 Stufe 2 Prüfverfahren erreicht. Eine solche Flexibilisierung erlaubt es uns, ohne die Beteiligung der DAkkS nach entsprechender Verifizierung bzw. Validierung neue, neu von uns modifizierte und von uns ganz neu entwickelte Prüfverfahren in diesem Prüfbereich in unseren Akkreditierungsumfang zu übernehmen. Dies erlaubt es uns, auch kurzfristig und unbürokratisch auf Kundenwünsche zu reagieren und diese zu befriedigen.